ホーム › 多発性骨髄腫 › ニューヨーク › Queens
Queens、NYにおける多発性骨髄腫の臨床試験
Queensとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第3相
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11マイル先
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第3相
- NYU Winthrop, Mineola · 11マイル先
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
被験者募集中第3相
- Northwell Health Cancer Institute, Lake Success · 9マイル先
- NYU Langone Hospital Long Island, Mineola · 11マイル先
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
被験者募集中第3相
- MSK Nassau, Uniondale · 13マイル先
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
被験者募集中第2相
- Queens Cancer Center, Rego Park · 3マイル先
- Cohen Children's Medical Center, New Hyde Park · 9マイル先
- Northwell Health Monter Cancer Center, Lake Success · 9マイル先
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
被験者募集中第2相
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
被験者募集中第3相
- Long Island Jewish Medical Center, New Hyde Park · 9マイル先
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9マイル先
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
被験者募集中第3相
- MSK Nassau, Uniondale · 13マイル先
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
被験者募集中第1相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
被験者募集中第3相
- Research Site, New Hyde Park · 9マイル先
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
被験者募集中観察研究
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10マイル先
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
被験者募集中第1/2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
被験者募集中第1/2相
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11マイル先
A Dietary Study for People With Multiple Myeloma
被験者募集中
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
被験者募集中第2相
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13マイル先
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Rockville, Rockville Centre · 10マイル先
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
被験者募集中
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13マイル先
他の都市における多発性骨髄腫の試験
- New York City, NY60件の研究
- Boston, MA42件の研究
- Atlanta, GA41件の研究
- Houston, TX38件の研究
- Durham, NC37件の研究
- Nashville, TN32件の研究
- Denver, CO27件の研究
- Rochester, MN24件の研究
- St. Louis, MO24件の研究
- Columbus, OH24件の研究
- Baldwin Park, CA23件の研究
- Chicago, IL22件の研究
Queensにおける他の研究
- 乳がん63件の研究
- 非小細胞肺癌49件の研究
- 大腸癌31件の研究
- 転移性癌28件の研究
- 卵巣がん28件の研究
- 前立腺がん27件の研究
- がん（全種類）26件の研究
- 子宮内膜がん25件の研究
- 肺がん22件の研究
- 急性骨髄性白血病21件の研究
- 頭頸部扁平上皮癌20件の研究
- 膵臓がん20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。